跳至主要内容
临床试验/NCT00933010
NCT00933010已完成不适用

Osservatorio Regionale Sulla Sindrome metabolicA

AstraZeneca2 个研究点 分布在 1 个国家目标入组 1,600 人开始时间: 2009年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,600
试验地点
2
主要终点
Prevalence of Metabolic Syndrome in Primary Care Population

研究概览

简要总结

The aim of the study is to assess the prevalence of Metabolic Syndrome in Italy on a regional basis, defined according to NCEP/ATPIII Guidelines criteria.

研究设计

研究类型
Observational
观察模型
Ecologic Or Community
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient aged between 18 and 75 years
  • Signed Informed consent
  • Laboratory analysis (lipidic profile and glycemia) performed in the last year

排除标准

  • Pregnancy or breast feeding
  • Patients enrolled in clinical studies which the aim is to evaluate the efficacy and/or tolerability of anti-hypertensive and/or lipid lowering drugs
  • Subjects with serious or unstable medical or psychological conditions that, in the opinion of the investigator, would compromise the subject's successful participation in the study

结局指标

主要结局

Prevalence of Metabolic Syndrome in Primary Care Population

时间窗: July 2009 - March 2010

Concomitant presence of other CV risk factors

时间窗: July 2009 - March 2010

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry

研究点 (2)

Loading locations...

相似试验